Functional Immunomics Core
Functional Immunomics Core
批准号:
10333207
负责人:
Bing Li
金额:
$50.15万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-02-01 至 2025-01-31
关键词:
Applications GrantsAreaBiological Specimen BanksBloodCancer CenterCancer PatientCell SeparationCellsCenters of Research ExcellenceClinicClinicalContract ServicesCore FacilityCytometryDNADataDatabasesDevelopmentEnsureExtramural ActivitiesFee-for-Service PlansFlow CytometryFreezingFundingFutureGenomicsGoalsHumanHuman ResourcesImmuneImmune systemImmunofluorescence ImmunologicImmunologic MonitoringImmunologicsImmunooncologyImmunotherapyInfrastructureInstitutionInvestmentsKentuckyLocationMalignant NeoplasmsMolecularMusParaffin EmbeddingPatientsPhasePhenotypeProcessProteinsProtocols documentationPublicationsRNAResearchResearch PersonnelResearch SupportResourcesRunningSamplingServicesSiteSlideSpecimenStainsTechnologyTissuesTrainingTraining and EducationTranslationsTumor TissueTumor-Associated ProcessUniversitiesUniversity resourcesWritingcancer immunotherapyclinical applicationdesignequipment acquisitioninnovationinstrumentinstrumentationinterestmembernew therapeutic targetnoveloperationprospectivesuccesstissue processingtissue/cell preparationtranscriptomicstreatment strategytumor immunology
中文摘要
功能免疫组学核心(Functional Immunomics Core)
功能免疫组学核心(FIC)的主要目标是作为中央基础设施实体,
支持癌症免疫学和免疫治疗中心(CCII)COBRE的所有研究人员。FIC
将利用机构资金购买的新设备,并利用大学的现有设施,
路易斯维尔为CCII中的小鼠和人类项目提供分子/细胞免疫分析。具体
目标1是在路易斯维尔大学建立一个功能性免疫组学设施。在CCII的支持下,我们
将在中心位置建立一个精简的最先进的免疫组学设施,
路易斯维尔大学的现有资源。这一独特的资源将作为一个重要的综合组成部分,
通过不仅为其成员提供集中服务,而且还为该机构提供集中服务,
整体具体目标2是利用全面和综合的FIC平台,以确保
CCII支持的项目。FIC的主要目标是支持发展,进步和成功
在其研究的所有阶段,建议CCII项目。特别是,FIC将提供人体样本
分析专业知识和技术服务,以支持CCII项目的具体目标。具体目标3是
促进转化癌症免疫学/免疫治疗研究,并发展一个自我维持的实体,
通过大学/区域服务的CCII。总而言之,通过与现有资源相结合,
UofL,新成立的FIC将提供全面的免疫组学服务中心,
CCII项目的建议和新的实验发现的临床应用的翻译。
英文摘要
SUMMARY (Functional Immunomics Core)
The primary goal of the Functional Immunomics Core (FIC) is to serve as the central infrastructure entity that
supports all the investigators in the Center for Cancer Immunology and Immunotherapy (CCII) COBRE. FIC
will utilize new equipment purchased with institutional funds and leverage existing facilities at the University of
Louisville to provide molecular/cellular immune profiling for mouse and human projects in the CCII. Specific
Aim 1 is to build a functional immunomics facility at the University of Louisville. With the support of CCII, we
will establish a streamlined state-of-the-art immunomics facility in a central location by incorporating the
existing resources of the University of Louisville. This unique resource will act as a vital integrative component
of the CCII through providing centralized services not only for its members but also for the Institution as a
whole. Specific Aim 2 is to utilize the comprehensive and integrative FIC platform to ensure the success of
CCII-supported projects. The major goal of the FIC will be to support the development, progress and success
of proposed CCII projects in all phases of their research. Particularly, the FIC will provide human sample
analytics expertise and technical services to support the specific aims of the CCII projects. Specific Aim 3 is
to facilitate translational cancer immunology/immunotherapy research and develop a self-sustaining entity of
the CCII through University/region-wide services. In summary, by integrating with the existing resources at the
UofL, the newly-established FIC will provide a comprehensive immunomics service center for the success of
the proposed CCII projects and the translation of novel experimental discoveries to clinical applications.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Determine the molecular and metabolic mechanisms by which A-FABP links dysregulated lipid metabolism-induced obesity/breast cancer risk
-
批准号:10683379
-
项目类别:
-
资助金额:$115.28万
-
财政年份:2022
-
负责人:Bing Li
-
依托单位:
Determine the molecular and metabolic mechanisms by which A-FABP links dysregulated lipid metabolism-induced obesity/breast cancer risk
-
批准号:10501614
-
项目类别:
-
资助金额:$117.85万
-
财政年份:2022
-
负责人:Bing Li
-
依托单位:
E-FABP mediates n-3 fatty acid-induced tumor prevention through epigenetic control of immune cell differentiation and function
-
批准号:10320058
-
项目类别:
-
资助金额:$34.07万
-
财政年份:2021
-
负责人:Bing Li
-
依托单位:
E-FABP mediates n-3 fatty acid-induced tumor prevention through epigenetic control of immune cell differentiation and function
-
批准号:10544533
-
项目类别:
-
资助金额:$34.07万
-
财政年份:2021
-
负责人:Bing Li
-
依托单位:
Immunomodulatory mechanisms of E-FABP in psoriasis pathogenesis
-
批准号:10478125
-
项目类别:
-
资助金额:$38.26万
-
财政年份:2021
-
负责人:Bing Li
-
依托单位:
E-FABP mediates n-3 fatty acid-induced tumor prevention through epigenetic control of immune cell differentiation and function
-
批准号:10459794
-
项目类别:
-
资助金额:$27.82万
-
财政年份:2021
-
负责人:Bing Li
-
依托单位:
Immunomodulatory mechanisms of E-FABP in psoriasis pathogenesis
-
批准号:10459902
-
项目类别:
-
资助金额:$38.64万
-
财政年份:2021
-
负责人:Bing Li
-
依托单位:
Functional Immunomics Core
-
批准号:10093107
-
项目类别:
-
资助金额:$50.39万
-
财政年份:2020
-
负责人:Bing Li
-
依托单位:
Functional Immunomics Core
-
批准号:10577767
-
项目类别:
-
资助金额:$46.69万
-
财政年份:2020
-
负责人:Bing Li
-
依托单位:
Immunomodulatory mechanisms of E-FABP in psoriasis pathogenesis
-
批准号:9790920
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2018
-
负责人:Bing Li
-
依托单位:
Prevention of Breast Cancer Development by Epidermal Fatty Acid Binding Protein (
-
批准号:9038740
-
项目类别:
-
资助金额:$32.99万
-
财政年份:2015
-
负责人:Bing Li
-
依托单位:
The role of adipocyte/macrophage fatty acid binding protein in breast cancer deve
-
批准号:8896574
-
项目类别:
-
资助金额:$31.81万
-
财政年份:2015
-
负责人:Bing Li
-
依托单位:
The role of adipocyte/macrophage fatty acid binding protein in breast cancer deve
-
批准号:9039350
-
项目类别:
-
资助金额:$33.06万
-
财政年份:2015
-
负责人:Bing Li
-
依托单位:
Prevention of Breast Cancer Development by Epidermal Fatty Acid Binding Protein (
-
批准号:9308675
-
项目类别:
-
资助金额:$31.8万
-
财政年份:2015
-
负责人:Bing Li
-
依托单位:
Prevention of Breast Cancer Development by Epidermal Fatty Acid Binding Protein (
-
批准号:8749759
-
项目类别:
-
资助金额:$32.3万
-
财政年份:2014
-
负责人:Bing Li
-
依托单位:
The role of adipocyte/macrophage fatty acid binding protein in breast cancer deve
-
批准号:8755020
-
项目类别:
-
资助金额:$32.29万
-
财政年份:2014
-
负责人:Bing Li
-
依托单位:
Mechanisms for chromatin modification during transcription elongation
-
批准号:8304963
-
项目类别:
-
资助金额:$29.9万
-
财政年份:2010
-
负责人:Bing Li
-
依托单位:
Structure-Based Design of Sortase Inhibitors for Anti-Infective Therapy
-
批准号:7909173
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2010
-
负责人:Bing Li
-
依托单位:
Structure-Based Design of Sortase Inhibitors for Anti-Infective Therapy
-
批准号:8033253
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2010
-
负责人:Bing Li
-
依托单位:
Mechanisms for chromatin modification during transcription elongation
-
批准号:8111192
-
项目类别:
-
资助金额:$29.81万
-
财政年份:2010
-
负责人:Bing Li
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: